arrow
BackJournal Details
Multiple Sclerosis Journal cover

Multiple Sclerosis Journal

IF5
Papers32120
Citations16621
Journal Papers 32120
Publication Date
Mapping myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD): A global review of publicly listed patient disease registries and databases
delete2026-11-11
delete0
PREAI
deleteJacqueline Palace; Romain Marignier; Aaron Abend; Simon A. Broadley; Edgar Carnero Contentti; Tanuja Chitnis; Gabrielle deFiebre; Eoin P. Flanagan; Massimo Filippi; Kazuo Fujihara; Lorna Galleguillos; Ruth Geraldes; Alejandra González; Benjamin Greenberg; Shahd Hamid; Jyh Yung Hor; Saif Huda; Ho Jin Kim; Ilya Kister; Julia Lefelar; Michael Levy; Silvia Messina; Andre Mochan; Ichiro Nakashima; Zoya Panahloo; Lekha Pandit; Stella Patsa; Aleksandra Podlecka-Piętowska; Sudarshini Ramanathan; Juan I. Rojas; Eitzaz Sadiq; Jonathan D. Santoro; Elias S. Sotirchos; Silvia Tenembaum; De-Cai Tian; Fu-Dong Shi; Michael R. Yeaman; Friedemann Paul
deleteShare
deleteSave
Myelin oligodendrocyte glycoprotein antibody–associated disease in a modern, population-based cohort
delete2026-11-05
delete0
PREAI
deleteAnnette M. Langer-Gould; Jason N. Scott; Jessica B. Smith; Fernando Torres
deleteShare
deleteSave
Multiple sclerosis relapse redefined: Effect of an MRI-supported relapse criterion on ublituximab outcomes in the ULTIMATE I and II trials
delete2026-11-03
delete0
PREAI
deleteStephen C. Krieger; Karthik Bodhinathan; Yihuan Xu; Hari P. Miskin; Enrique Alvarez
deleteShare
deleteSave
Emergence of natalizumab anti-drug antibodies during extended interval dosing in a patient with multiple sclerosis: A case report
delete2026-11-02
delete0
PREAI
deleteLiza M. Y. Gelissen; Stefan P. H. van den Berg; Thomas P. C. Dorlo; Gertjan Wolbink; Bob W. van Oosten; Joep Killestein; Zoé L. E. van Kempen; Theo Rispens
deleteShare
deleteSave
Ocrelizumab treatment and disability progression in non-Hispanic Black and Hispanic or Latino individuals with relapsing multiple sclerosis: A post hoc analysis of the OPERA I and II trials
delete2026-10-28
delete0
PREAI
deleteLilyana Amezcua; Devi Sai Sri Kavya Boorgu; Jake Oxendine; Ibraheem Abioye; Tushar Bhangale; Christopher Harp; Chien-Ju Lin; Nicolas Strauli; Akshaya Ramesh; Bruce A. C. Cree; Mitzi J. Williams; Xiaoming Jia
deleteShare
deleteSave
Multimodal effects of CD40L blockade in multiple sclerosis: Insights from preclinical and clinical studies
delete2026-10-27
delete0
PREAI
deleteIsmail Muwenda; Joshua S. Mytych; Ekdanai Uawithya; Megan Reidy; Meerah Khan; Yang Mao-Draayer
deleteShare
deleteSave
Availability of resources to apply the 2024 McDonald criteria: A global perspective
delete2026-10-23
delete0
PREAI
deleteNatalia Gómez-Salazar; Paola A. Ortíz-Salas; Rebecca Wicklein; Charmaine Yam; Mateo Avilés-Gómez; Magdalena Casas; Marija Cauchi; Sofía D’Alessandro; Michela Galimberti; Panagiotis Gklinos; Fernando Maldonado-Higuera; Suhamny Navas-Peñaranda; Tatchaporn Ongphichetmetha; Alejandro A. Pelaez-Suarez; Wilson A. Polo-Orcasitas; André L. Guimarães de Queiroz; Audrey Reynolds; Neda Sattarnezhad; Raquel Tena-Cucala; Oana Vladacenco; Mario M. Barbosa-Rengifo; Wallace Brownlee; Mar Tintoré
deleteShare
deleteSave
Author response—Rituximab versus ocrelizumab: When inference exceeds the evidence
delete2026-10-18
delete0
PREAI
deleteNathan Y. Chu; Jodie I. Roberts; Alice J. Schabas
deleteShare
deleteSave
Rituximab versus ocrelizumab: When inference exceeds the evidence
delete2026-10-18
delete0
PREAI
deleteFredrik Piehl; Thomas Frisell; Kjell-Morten Myhr; Øivind Torkildsen
deleteShare
deleteSave
Increased autoimmune disease burden before multiple sclerosis and neuromyelitis optica spectrum disorder diagnosis: A nationwide Korean cohort study
delete2026-10-17
delete0
PREAI
deleteSoonwook Kwon; Jinhee Kim; Yeon Hak Chung; Bongseong Kim; Kyungdo Han; Dong Wook Shin; Ju-Hong Min
deleteShare
deleteSave
Lymphocytosis as a biomarker for natalizumab treatment response in multiple sclerosis: The link with anti-drug antibodies
delete2026-10-17
delete0
PREAI
deleteEster Valero-Hernandez; Jai Mathur; David Baker; Iris Y. H. Liu; Sarah L. Morgan; Emma C. Tallantyre; Klaus Schmierer; Angray S. Kang
deleteShare
deleteSave
Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry
delete2026-10-14
delete0
PREAI
deletePietro Iaffaldano; Saverio D’Amico; Giuseppe Lucisano; Massimiliano Copetti; Tommaso Guerra; Maria A. Rocca; Francesco Patti; Giovanna De Luca; Diana Ferraro; Rocco Totaro; Vincenzo Brescia Morra; Giuseppe Salemi; Emilio Portaccio; Matteo Foschi; Matilde Inglese; Maria G. Coniglio; Clara G. Chisari; Francesca Caputo; Damiano Paolicelli; Mario A. Battaglia; Matteo G. Della Porta; Victor Savevski; Mattia Delleani; Filippo E. Colella; Elisabetta Sauta; Maria P. Amato; Massimo Filippi; Maria Trojano
deleteShare
deleteSave
Survivor bias and disease progression in observational cohorts in multiple sclerosis
delete2026-10-14
delete0
PREAI
deleteMark H. J. Wessels; Daan J. de Jong; Mar Barrantes-Cepas; Julia R. Jelgerhuis; Zoë van Lierop; Eline van Daele; Anna L. Wojdała; Tom A. N. Fuchs; Marloes M. D. A. Bet; David R. van Nederpelt; Ismail Koubiyr; Martijn D. Steenwijk; Hugo Vrenken; Bastiaan Moraal; Frederik Barkhof; Bernard M. J. Uitdehaag; Charlotte E. Teunissen; Joep Killestein; Menno M. Schoonheim; Eva M. M. Strijbis
deleteShare
deleteSave
How well do junior neurology residents recognize multiple sclerosis? Analysis of the “Close the Loop” resident clinical acumen project
delete2026-10-12
delete0
PREAI
deleteClaudia Zbrzeski; Emily M. Schorr; Sai P. Polineni; Rachel Brandstadter; Michelle T. Fabian; Stephen C. Krieger
deleteShare
deleteSave
Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with AIRE gene dominant-negative mutation
delete2026-10-08
delete0
PREAI
deleteLinling Wang; Ruiwen Hu; Lei Chen; Jingqi Wang; Jiahao Lin; Rui Li; Xueqiang Hu; Wei Qiu; Xiaonan Zhong; Tingting Lu
deleteShare
deleteSave
How patients with neuromyelitis optica spectrum disease accumulate disability
delete2026-10-08
delete0
PREAI
deleteSifat Sharmin; Izanne Roos; Pakeeran Siriratnam; Serkan Ozakbas; Dana Horáková; Eva Kubala Havrdova; Petra Nytrová; Recai Turkoglu; Francesco Patti; Bassem Yamout; Samia J. Khoury; Abdullah Al-Asmi; Guy Laureys; Raed Alroughani; Jeannette Lechner-Scott; Cavit Boz; Ayse Altintas; Aysun Soysal; Sara Eichau; Anneke van der Walt; Vilija Jokubaitis; Helmut Butzkueven; Mastura Monif; Tomas Kalincik
deleteShare
deleteSave